-
1تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: An Open Label, Phase II Investigator Initiated Study of Venetoclax and Acalabrutinib in Previously Treated Relapsed/Refractory Patients With Mantle Cell Lymphoma (MCL)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03946878Test
Other URLs: http://www.mdanderson.orgTest
-
2تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase I Trial of Ipilimumab (Immunotherapy) and Imatinib Mesylate (c-Kit Inhibitor) in Patients With Advanced Malignancies
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01738139Test
Other URLs: http://www.mdanderson.orgTest